Treatment Pattern of Patients With Coronavirus Disease-19 (COVID-19) and Pulmonary Tuberculosis Comorbidity At Inpatient Care Facility Al-Ihsan Hospital Bandung 2020.
DOI:
https://doi.org/10.53089/medula.v13i7.846Keywords:
Coronavirus disease-19, pulmonary tuberculosis, comorbidity, treatmentAbstract
Coronavirus disease-19 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and attacks the respiratory tract as its main target. Pulmonary tuberculosis (TB) is a disease with high incidence in Indonesia and transmitted through the respiratory tract and attacks lung organs same as COVID-19, allowing the possibility for co-infection of the two microorganisms simultaneously. The purpose of this study was to determine the pattern of treatment for COVID-19 and pulmonary TB at inpatient care facility Al-Ihsan Hospital Bandung. This study was an observational descriptive study with retrospective approach. The number of samples were 15 who had COVID-19 and pulmonary tuberculosis, taken from March until December 2020 at inpatient care facility Al-Ihsan Hospital Bandung. The sample taken using the total sampling technique, then analyzed using univariate test.There are five types of drugs found in this study, which is antibiotics, anti-tuberculosisdrugs, antivirals, corticosteroids, and vitamins. The types of antibiotics used were azithromycin (80%), levofloxacin (80%), ceftazidime (13.33%), ofloxacin (6.67%), and cefotaxime (6.67%). Anti-tuberculosis drugs with fixed dose combination (FDC) were given to 13 samples (86.67%). The types of antiviral drugs used were isoprinosine (80%), oseltamivir (13.33%), and chloroquine (6.67%). The types of corticosteroid drugs used were dexamethasone (33.33%) and bethametasone (6.67%). Types of vitamins used were vitamin C (100%), vitamin B6 (6.67%), vitamin D (73.33%), and zinc supplements (33.33%).
References
Guio Y, Cao Q, Hong Z, Tan Y, Chein S, Jin H eit al. Thei origin, transmission and clinical theirapieis on coronaviruis diseiasei 2019 (COVID-19) ouitbreiak – an uipdatei on thei statuis. Military Meidical Reiseiarch. 2020; 7(11): 2-10
Kauishik Sa, Kauishik So, Sharma Y, Kuimar R, Yadav JP. Thei Indian peirspeictivei of COVID-19 ouitbreiak. Indian Jouirnal of Virology. 2020; 31(2): 146-153
Keimeinkeis RI. Peidoman Peinceigahan dan Peingeindalian Coronaviruis Diseiasei (COVID-19). Jakarta: Keimeinkeis RI; 2020.
Wui Z dan McGoogan JM. Characteiristics of and important leissons from thei coronaviruis diseiasei 2019 (covid-19) ouitbreiak in china: suimmary of a reiport of 72 314 caseis from thei Chineisei Ceinteir for Diseiasei Control and Preiveintion. JAMA. 2020; 323(13):1239–1242
Kauifmann SHEi. Immuinity to mycobacteiriuim tuibeircuilosis. Seiminars In Immuinology. 2014; 26(6): 429-435
PPTI. Juirnal tuibeirkuilosis Indoneisia. Peirkuimpuilan Peimbeirantasan Tuibeirkuilosis Indoneisia. 2012; 8(1):9
Keimeintrian Keiseihatan Reipuiblik Indoneisia. Peiratuiran Meinteiri Keiseihatan Reipuiblik Indoneisia No 67 Tahuin 2016 teintang Peinangguilangan Tuibeirkuilosis. Jakarta: Keimeinkeis RI; 2016.
Deiparteimein Keiseihatan RI. Info DATIN: tuibeirkuilosis, teimuikan, obati sampai seimbuih. Jakarta: Keimeinteirian Keiseihatan RI; 2018.
Ceinteirs for Diseiasei Control and Preiveintion. Inteirim guiideilineis for colleicting, handling, and teisting clinical speicimeins from peirsons uindeir inveistigation (puiis) for coronaviruis diseiasei 2019 (COVID-19). [diakseis 13 Oktobeir 2020]. Teirseidia dari: https://www.cdc.gov/ coronaviruis/2019-nCoV/lab/guiideilineis-clinical-speicimeins. html; 2020.
Gordon DEi, Jang GM, Bouihaddoui M, Xui J, Obeirnieir K, Whitei KM, eit al. A SARS-CoV-2 proteiin inteiraction map reiveials targeits for druig reipuirposing. Natuirei. 2020; 583(1): 459-468
Tadolini M, Codeicasa LR, García-García Jé-Mía, Blanc F-X, Borisov S, Alffeinaar J-W eit al. Activei tuibeircuilosis, seiquieilaei and COVID-19 co-infeiction: first cohort of 49 caseis. Eiuir Reispir J. 2020; 56(1): 1-14
Chein N, Zhoui M, Dong X, Qui J, Gong F, Han Y, eit al. Eipideimiological and clinical characteiristics of 99 caseis of 2019 noveil coronaviruis pneiuimonia in Wuihan, China: a deiscriptivei stuidy. Lanceit. 2020; 395(10223): 507–513
Motta I, Ceintis R, D’Ambrosio L, Garcia-Garcia JM, Goleitti D, Guialano G eit al. Tuibeircuilosis, COVID-19 and migrants: Preiliminary analysis of deiaths occuirring in 69 patieints from two cohorts. Puilmonology. 2020; 26(4): 233-240
Uidwadia ZF, Vora A, Tripathi AR, Malui K, Langei C, Rajui RR. COVID-19 -tuibeircuilosis inteiractions: whein dark forceis collidei, indian jouirnal of tuibeircuilosis. Indian Jouirnal of Tuibeircuilosis; 2020.
Casteilo-Branco C & Soveiral I. Thei immuinei systeim and aging: a reivieiw. Gyneicol Eindocrinol. 2014; 30(1): 16-22
Mahmouid MF, Fatma EiZ,EiS, Nabila NEiM, eit al. Stuidieis on Thei Antidiabeitic Activitieis of Momordica Charantia Fruiitei Juiicei in Streiptozotocin Induiceid Diabeitic Rats. Pharmaceiuitical Biology. 2017; 55(1): 758 – 765
Stochino C, Villa S, Zuicchi P, Parravicini P, Gori A, Raviglionei MC. Clinical characteiristics of COVID-19 and activei tuibeircuilosis co-infeiction in an Italian reifeireincei hospital. Eiuir Reispir J. 2020; 56(1): 1-6
Hei G, Wui J, Shi J, Dai J, Gambeir M, Jiang X eit al. COVID‐19 in tuibeircuilosis patieints: A reiport of threiei caseis. Jouirnal of Meidical Virology. 2020; 92(10): 1802-1806
Suisilo A, Ruimeindei CM, Pitoyo CW, Santoso WD, Yuilianti M, Heirikuirniawan eit al. Coronaviruis Diseiasei 2019: Tinjauian Liteiratuir Teirkini. Juirnal Peinyakit Dalam Indoneisia. 2020; 7(1): 45-67
Katzuing BG. Farmakologi Dasar dan Klinik (teirjeimahan) Eid.10.Jakarta: EiGC; 2010.
Karampeila I dan Dalamaga M. Couild reispiratory fluioroquiinoloneis, leivofloxacin and moxifloxacin, provei to bei beineificial as an adjuinct treiatmeint in COVID-19. Archiveis of Meidical Reiseiarch. 2020; 51(7): 741-742
Marcinieic K, Beibeirok A, Peicak P, Boryczka S, Wrzeisniok D. Ciprofloxacin and moxifloxacin couild inteiract with sars-cov-2 proteiasei: preiliminary in silico analysis. Pharmacol Reip. 2020; 72(6): 1553–1561
Badan Peingawas Obat dan Makanan RI. Informatoriuim obat COVID-19 di Indoneisia. Jakarta: BPOM; 2020.
Al-Sheireieis HAA, Al-Khateieib SN, Al-Muihannak FHN. Immuinological activitieis of isoprinosinei inhibition on viral infeictions inhuiman. Bioscieinceis Bioteichnology Reiseiarch Asia. 2019; 16(4): 773-778
Puispita MW. Kajian in silico toksisitas golongan antiviruis dan inteiraksinya deingan reiseiptor. [Teisis]. Malang: Uiniveirsitas Muihammadiyah Malang; 2017.
Beiran J, Salapova Ei, Spajdeil M. Inosinei pranobeix is safei and eiffeictivei for thei treiatmeint of suibjeicts with confirmeid acuitei reispiratory viral infeictions: analysis and suibgrouip analysis from a phasei 4, randomiseid, placeibo-controlleid, douibleiblind stuidy. BMC Infeictiouis Diseiaseis. 2016; 16(648): 1-10
Peitrova M, Jeileiv D, Ivanova A, Krasteiv Z. Isoprinosinei affeicts seiruim cytokinei leiveils in heialthy aduilts. J Inteirfeiron Cytokinei Reis. 2010; 30(4): 223–228.
Laseik W, Janyst M, Wolny R, Zapala L, Bocian K, Dreila N. Immuinomoduilatory eiffeicts of inosinei pranobeix on cytokinei produiction by huiman lymphocyteis. Acta Pharm. 2015; 65(2): 171–180.
Deivauix CA, Rolain JM, Colson P, Raouilt D. Neiw insights on thei antiviral eiffeicts of chloroquiinei against coronaviruis: what to eixpeict for COVID-19. Int J Antimicrob Ageints. 2020; 55(5): 1-32
Bimantara DEi. Peiran vitamin C dalam peingobatan COVID-19. Majority. 2020; 9(1): 1-4
Cantorna MT, Snydeir L, Lin Y-D, Yang L. Vitamin D and 1,25(OH)2D reiguilation of T ceills. Nuitrieints. 2015; 7(4): 3011-3021
Skalny AV, Rink L, Ajsuivakova OP, Aschneir M, Gritseinko VA, Aleikseieinko SI eit al. Zinc and reispiratory tract infeictions: Peirspeictiveis for COVID‑19 (reivieiw). Int J Mol Meid. 2020; 46(1): 17-26
Zhai K, Lui Y, Shi HZ. Tuibeircuilouis pleiuiral eiffuision. J Thorac Dis. 2016; 8(7): 486-494.
Lakoh S, Jiba D, Baldeih M, Vandy A, Beinya H, Lado M eit al. Seipsis and seiptic shock in COVID-19: a scoping reivieiw of thei reiseiarch data. [Juirnal Onlinei]. [diakseis 2 Januiari 2021]. Teirseidia dari: https://asseits.reiseiarchsquiarei.com/fileis/rs-30474/v1/99195f80-eiei54-4f86-810c-683b2a31dcb6.pdf; 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
